Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues.
about
Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic)Advancing the Minimal Residual Disease Concept in Acute Myeloid LeukemiaThe Impact of Normalization Methods on RNA-Seq Data Analysis.Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia.A multigene array for measurable residual disease detection in AML patients undergoing SCTCancer-testis antigen cyclin A1 is broadly expressed in ovarian cancer and is associated with prolonged time to tumor progression after platinum-based therapy.The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell-based immunotherapySystematic Prioritization of Druggable Mutations in ∼5000 Genomes Across 16 Cancer Types Using a Structural Genomics-based ApproachImmunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia.Adenosine Selectively Depletes Alloreactive T Cells to Prevent GVHD While Conserving Immunity to Viruses and Leukemia.Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy.Immunological effects of hypomethylating agents.Leukemic progenitor cells are susceptible to targeting by stimulated cytotoxic T cells against immunogenic leukemia-associated antigens.
P2860
Q26770391-BBC90C55-C032-4F0B-B646-DB2D5A3B5104Q28087291-A1C68172-B0C9-4748-BB3A-09FE51D1E780Q30980468-9216ED9A-C275-4008-BC03-A405AB55236CQ35546759-CDE3B657-7561-4CF6-8FA8-13A388E468F2Q35582360-8119DCCC-47BE-42A5-B75B-46C476EE2F31Q35820674-BFC3A9D6-0B60-4543-BBEE-569B98475844Q36169794-1F32A870-6E52-432D-A4E4-CF35788A1E7EQ36539506-8E178E50-8F38-481E-A639-D361488A1A3DQ38485334-888EE030-CBD0-42FB-8F6C-89491BA64439Q40657274-B2263D79-EA35-49C7-A44F-D7C09C4DEF99Q44976497-0A354202-5767-435D-9E9F-9F315602E3B2Q48229616-0441372B-362A-4DCE-B06B-A9CF002B9DBAQ50447093-AB1BCC83-A159-4E11-93AF-A59A32095B3F
P2860
Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Expression of putative targets ...... leukemia and healthy tissues.
@en
Expression of putative targets ...... leukemia and healthy tissues.
@nl
type
label
Expression of putative targets ...... leukemia and healthy tissues.
@en
Expression of putative targets ...... leukemia and healthy tissues.
@nl
prefLabel
Expression of putative targets ...... leukemia and healthy tissues.
@en
Expression of putative targets ...... leukemia and healthy tissues.
@nl
P2093
P2860
P356
P1433
P1476
Expression of putative targets ...... d leukemia and healthy tissues
@en
P2093
A J Barrett
B N Savani
G T Prince
H I Levitsky
H Sadrzadeh
J W Fraser
M Battiwalla
P2860
P2888
P304
P356
10.1038/LEU.2014.14
P577
2014-01-10T00:00:00Z
P5875
P6179
1017990758